SEC Filing Summary for Arthur A. Levin

Arthur A. Levin, a director at Avidity Biosciences, Inc., reported a disposition of 1330 common stock shares on December 19, 2025. The transaction, coded as a gift (G) with a price of $0.00, resulted in a decrease in directly held shares. Following this transaction, Levin directly holds 18,320 shares. Additionally, Levin has indirect ownership of 131,372 shares held through a family trust and 22,500 shares held through a charitable remainder trust. The filing is a Form 4, indicating a change in beneficial ownership.